COMMUNIQUÉS West-GlobeNewswire

-
FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference
02/04/2025 -
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/04/2025 -
Compass Therapeutics to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
02/04/2025 -
GRI Bio Announces Closing of $5.0 Million Public Offering
02/04/2025 -
Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update
02/04/2025 -
eXoZymes Provides Fourth Quarter and Full Year 2024 Update
02/04/2025 -
Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)
02/04/2025 -
Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14
02/04/2025 -
NeuroPace Announces Refocusing of Product Portfolio
02/04/2025 -
Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors
02/04/2025 -
Elutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology Makes
02/04/2025 -
BioCryst to Present at Upcoming Investor Conference
02/04/2025 -
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
02/04/2025 -
EssilorLuxottica: EssilorLuxottica’s employee shareholding plans reach record investment, reflecting strong confidence in the Group’s strategy
02/04/2025 -
EssilorLuxottica: L’actionnariat salarié d’EssilorLuxottica atteint un investissement record, un signe fort de confiance dans la stratégie du Groupe
02/04/2025 -
Arcutis and Padagis Agree to Stay Patent Lawsuit
02/04/2025 -
Early Warning News Release
02/04/2025 -
TeamHealth and Array Behavioral Care partner to transform emergency behavioral health treatment
02/04/2025 -
Roche provides update on Phase III OCREVUS high dose study in people with relapsing multiple sclerosis
02/04/2025
Pages